Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Net Cash Flow (2020 - 2025)

Celularity has reported Net Cash Flow over the past 6 years, most recently at -$681000.0 for Q3 2025.

  • Quarterly results put Net Cash Flow at -$681000.0 for Q3 2025, down 205.38% from a year ago — trailing twelve months through Sep 2025 was -$76000.0 (up 98.41% YoY), and the annual figure for FY2024 was $814000.0, up 104.37%.
  • Net Cash Flow for Q3 2025 was -$681000.0 at Celularity, down from $632000.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for CELU hit a ceiling of $64.5 million in Q3 2021 and a floor of -$35.4 million in Q4 2021.
  • Median Net Cash Flow over the past 5 years was -$1.4 million (2024), compared with a mean of -$3.1 million.
  • Peak annual rise in Net Cash Flow hit 230.07% in 2021, while the deepest fall reached 7520.18% in 2021.
  • Celularity's Net Cash Flow stood at -$35.4 million in 2021, then grew by 18.9% to -$28.7 million in 2022, then surged by 82.79% to -$4.9 million in 2023, then soared by 113.09% to $646000.0 in 2024, then plummeted by 205.42% to -$681000.0 in 2025.
  • The last three reported values for Net Cash Flow were -$681000.0 (Q3 2025), $632000.0 (Q2 2025), and -$673000.0 (Q1 2025) per Business Quant data.